ULURU Inc. announced the further expansion of the Altrazeal(R) international marketing network to include Croatia, Slovenia, Serbia, Montenegro, Macedonia, Bosnia, Kosovo and Albania. Marketing and distribution agreements have been signed for this territory for the exclusive marketing and distribution of Altrazeal(R). It is anticipated that Altrazeal(R) will be launched in these markets in the fourth quarter 2013.

Altrazeal(R) is a scientifically engineered advanced wound dressing designed to incorporate the desired features and benefits of the ideal wound dressing. Altrazeal(R) competes in the advanced wound dressing market which, worldwide, is estimated to be $6.5 billion growing annually at 13%. Altrazeal(R) has demonstrated potential clinical and economic advantages in a number of chronic and acute wounds including diabetic foot ulcers, venous leg ulcers and geriatric wounds.